Core Viewpoint - The article discusses the challenges faced by Yan Zhi Wu, a leading brand in the bird's nest industry, as it attempts to pivot towards the male consumer market while grappling with declining sales and the controversy surrounding its high-priced products [3][4]. Company Performance - Yan Zhi Wu reported a revenue of 2.05 billion yuan for 2024, reflecting a slight increase of 4.37% year-on-year, but its net profit fell by 24.18% to 156 million yuan, marking the first negative growth in five years [3]. - The company's stock price has halved since its peak in 2024, with a market capitalization of less than 3 billion HKD as of March 21 [3]. Marketing Strategy - The company has invested heavily in sales and marketing, with expenses reaching 671 million yuan, accounting for 32.7% of total revenue, while research and development spending was only 28.54 million yuan, less than 5% of marketing costs [4]. - The launch of the "President Bowl Bird's Nest," marketed towards high-net-worth males, is seen as an attempt to break through growth bottlenecks, as the previous core consumer base of women aged 30-50 has become saturated [4]. Market Dynamics - The male health supplement market in China is projected to approach 100 billion yuan in 2024, presenting a new growth opportunity for Yan Zhi Wu [4]. - However, the relevance of bird's nest products to male consumers remains questionable, as initial sales of the new product were disappointing, with only 30 boxes sold in the first three days [4]. Brand Perception - Yan Zhi Wu's brand has been historically associated with high-end female consumers, making the transition to a male-oriented market challenging [4]. - The company relies heavily on its pure bird's nest product line, which accounts for over 90% of its revenue, and faces difficulties in diversifying its product offerings [4]. Industry Trends - The shift from a "wealthy women's economy" to a "male elite narrative" reflects broader anxieties within the traditional health supplement industry [5]. - As consumers become more rational, the industry faces the urgent challenge of using scientific backing to dispel the "intelligence tax" label and innovate products for diverse consumption scenarios [5].

Summary of Yanzhi House Conference Call Company Overview - **Company**: Yanzhi House - **Year**: 2024 - **Revenue**: 2.05 billion CNY - **Profit**: 160 million CNY - **Revenue Structure**: Online channels accounted for 60.6%, while offline channels accounted for 39.4% [3][4] Key Financial Metrics - **Online Gross Margin**: 45% - **Offline Gross Margin**: 55.7% - **Sales Expense Ratio**: Increased to 32.7% from 28.7% - **Management Expense Ratio**: Decreased to 6.6% from 8.1% - **R&D Expense Ratio**: Maintained at approximately 1.4% [4][5][6] Sales and Marketing Strategies - **Brand Endorsement**: Utilized dual celebrity endorsement strategy with Gong Li and Wang Yibo, leading to a 47% increase in online traffic and a 36% increase in total transaction users [4][7] - **Membership Growth**: Registered members exceeded 8.3 million, enhancing targeted marketing efforts [4][11] - **Online Sales Growth**: Achieved a 12.5% increase in online sales, surpassing industry average growth [11] Product Development and Innovation - **Product Mix**: Pure bird's nest products remained stable, while bird's nest plus and derivative products increased from 7.2% to 11.3% of total sales [4][5] - **New Product Launches**: Introduced various innovative products, including bird's nest porridge, which achieved a revenue target of 90 million CNY in 2024 [12][21] Market Expansion - **International Presence**: Opened stores in Flushing, New York, and plans to open in Singapore. Products are now available in California Costco and other premium supermarkets [4][8] - **Channel Strategy**: Focused on optimizing existing channels in high-tier cities and expanding into top 100 counties and major supermarkets [13][19] Research and Development - **Industry Standards**: Led the drafting of industry standards for bird's nest products and collaborated with Peking University for human trials on fresh bird's nest [9] - **Health Research**: Engaged in research on the health benefits of bird's nest, including partnerships with other health brands [9][21] Future Growth Plans - **Revenue Doubling Goal**: Aiming to double revenue in the next five years by deepening the value of bird's nest and expanding health ecosystems [10] - **Product Strategy**: Focus on high-end positioning while meeting diverse consumer needs with a range of products [10][22] - **Marketing Adjustments**: Plans to reduce hard advertising costs in favor of deeper interactions with brand ambassadors [24] Challenges and Responses - **Sales Performance in Specific Markets**: Addressed poor sales in Guiyang and Nanning by reclaiming market control from underperforming distributors [19] - **Offline Sales Pressure**: Maintained offline advantages through high-end channel networks and customer engagement strategies [16] Financial Outlook - **2025 Projections**: Anticipates double-digit growth in both revenue and profit, with a focus on balancing profit margins with sales growth [25]

XIAMEN YAN PALACE BIRD'S NEST INDUSTRY CO., LTD. 廈門燕之屋燕窩產業股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：1497） 董事名單與其角色和職能 廈門燕之屋燕窩產業股份有限公司董事（「董事」）會（「董事會」）成員載列如下。 執行董事 黃健 （主席） 鄭文濱 李有泉 黃丹艷 非執行董事 劉震 獨立非執行董事 肖偉 陳愛華 林曉波 1 董事會設立四個委員會。下表提供各董事會成員在這些委員會中所擔任的職位。 | | | | 薪酬與 | | | | --- | --- | --- | --- | --- | --- | | | 審計委員會 | | 考核委員會 | 提名委員會 | 戰略委員會 | | 黃健 （主席） | | | | | C | | 鄭文濱 | | | | | M | | 李有泉 | | | M | | | | 黃丹艷 | | | | M | | | 劉震 | | | | | | | 王亞龍 | | | | | | | 肖偉 | | M | C | C | | | 陳愛華 | | C | M | M | | | 林曉波 | | M ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 XIAMEN YAN PALACE BIRD'S NEST INDUSTRY CO., LTD. (ii) 執行董事黃丹艷女士已獲委任為提名委員會成員；及 (iii) 獨立非執行董事及提名委員會現任成員肖偉先生已獲委任為提名委員會主席。 經上述變動後，提名委員會將由肖偉先生（主席）、陳愛華先生及黃丹艷女士組 成。 上述變動乃應將於2025年3月14日生效的經修訂企業管治守則及香港聯合交易所 有限公司證券上市規則而作出。良好的企業管治對本公司的整體表現發揮重要作 用，董事會認為，實施有關變動可增強董事會的效力及多元化，進一步提升本公 司整體的良好企業管治常規。 （股份代號：1497） 提名委員會組成變動 廈門燕之屋燕窩產業股份有限公司（「本公司」及其附屬公司（統稱「本集團」））董 事（「董事」）會（「董事會」）宣佈以下本公司提名委員會（「提名委員會」）組成變 動，自2025年3月14日起生效： (i) 本 ...

免責聲明 | 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 | | --- | --- | | 股票發行人現金股息公告 | | | 發行人名稱 | 廈門燕之屋燕窩產業股份有限公司 | | 股份代號 | 01497 | | 多櫃檯股份代號及貨幣 | 不適用 | | 相關股份代號及名稱 | 不適用 | | 公告標題 | 截至2024年12月31日止年度之末期股息 | | 公告日期 | 2025年3月14日 | | 公告狀態 | 新公告 | | 股息信息 | | | 股息類型 | 末期 | | 股息性質 | 普通股息 | | 財政年末 | 2024年12月31日 | | 宣派股息的報告期末 | 2024年12月31日 | | 宣派股息 | 每 10 股 2.15 RMB | | 股東批准日期 | 2025年5月9日 | | 香港過戶登記處相關信息 | | | 派息金額及公司預設派發貨幣 | HKD， 金額有待公佈 | | 匯率 | 有待公佈 | | 除淨 ...

Financial Performance - Revenue increased by 4.37% from RMB 1,964.2 million for the year ended December 31, 2023, to RMB 2,050.0 million for the year ended December 31, 2024[3]. - Gross profit rose by 1.79% from RMB 994.9 million for the year ended December 31, 2023, to RMB 1,012.8 million for the year ended December 31, 2024[3]. - Profit decreased by 24.18% from RMB 211.6 million for the year ended December 31, 2023, to RMB 160.4 million for the year ended December 31, 2024[3]. - Operating profit declined from RMB 276.2 million in 2023 to RMB 213.6 million in 2024[4]. - Basic and diluted earnings per share decreased from RMB 0.46 in 2023 to RMB 0.34 in 2024[4]. - Other comprehensive income for the year was RMB 13.9 million, with total comprehensive income for the year at RMB 174.4 million compared to RMB 211.6 million in 2023[5]. - The company reported other net income of RMB 39,462,000 in 2024, an increase from RMB 30,502,000 in 2023, which is a growth of around 29.4%[23]. - The company’s pre-tax profit for 2024 was RMB 206,613,000, down from RMB 273,326,000 in 2023, representing a decline of about 24.4%[22]. - The company's profit attributable to ordinary equity shareholders for 2024 was RMB 156,295 thousand, down 22.4% from RMB 201,218 thousand in 2023[30]. - The actual tax expense for 2024 was RMB 46,183 thousand, a decrease of 25.3% from RMB 61,738 thousand in 2023[30]. - Income tax decreased by 25.20% from RMB 61.7 million for the year ended December 31, 2023, to RMB 46.2 million for the year ended December 31, 2024, mainly due to a reduction in profits[91]. - Major financial ratios showed a decline in gross profit margin from 50.7% in 2023 to 49.4% in 2024, and net profit margin decreased from 10.8% to 7.8% during the same period[109]. Assets and Liabilities - Total assets decreased from RMB 1,154.5 million in 2023 to RMB 1,013.5 million in 2024[7]. - Net assets decreased from RMB 796.9 million in 2023 to RMB 768.2 million in 2024[8]. - Cash and cash equivalents decreased from RMB 537.1 million in 2023 to RMB 420.5 million in 2024[7]. - Trade receivables increased to RMB 163,656 thousand in 2024, up 36.0% from RMB 120,297 thousand in 2023[35]. - Trade payables rose to RMB 66,895 thousand in 2024, an increase of 7.2% from RMB 62,525 thousand in 2023[38]. - The company’s total liabilities, including trade and other payables, amounted to RMB 271,050 thousand in 2024, compared to RMB 260,107 thousand in 2023, indicating a growth of 4.0%[38]. Expenses - Research and development expenses increased from RMB 26.4 million in 2023 to RMB 28.5 million in 2024[4]. - Administrative expenses decreased to RMB 139,343,000 in 2024 from RMB 159,506,000 in 2023, showing a reduction of approximately 12.6%[22]. - Sales cost rose by 7.01% from RMB 969.3 million in 2023 to RMB 1,037.2 million in 2024, in line with revenue growth[84]. - Sales and distribution expenses grew by 19.08% from RMB 563.3 million in 2023 to RMB 670.8 million in 2024, primarily due to increased advertising and promotion costs[86]. - Financial costs, primarily from lease liabilities, increased to RMB 6,950,000 in 2024 from RMB 2,919,000 in 2023, reflecting a rise of approximately 138.5%[24]. - Employee costs for the year ending December 31, 2024, are estimated at RMB 292.8 million, including salaries, performance bonuses, and other incentives[114]. Revenue Sources - Revenue from online sales directly to customers was RMB 911,729,000 in 2024, up from RMB 824,397,000 in 2023, indicating a growth of about 10.6%[22]. - The total revenue from e-commerce business reached RMB 1.24 billion, contributing 60.6% to the overall revenue, with a year-on-year growth of 12.5%[57]. - The offline business revenue for the year ended December 31, 2024, was RMB 808 million, accounting for 39.4% of the total revenue, a decrease of 6.1% compared to the previous year[60]. - Revenue from pure bird's nest products in 2024 was RMB 1.8 billion, a slight increase of 0.1% compared to 2023, accounting for 87.6% of total revenue[66]. - Revenue from bird's nest + and + bird's nest products surged by 63.31%, from RMB 142.0 million in 2023 to RMB 231.9 million in 2024, driven by significant sales growth of bird's nest porridge[82]. Market and Growth Strategies - The company aims to achieve a strategic goal of doubling revenue in five years, focusing on expanding its product matrix and enhancing market penetration[78]. - Plans to open physical stores in New York and Singapore by 2025, alongside launching cross-border e-commerce in the U.S. and Southeast Asia[78]. - The company is actively expanding its international presence, opening its first store in Flushing, New York, and entering Chinese supermarkets in California[61]. - The company is exploring opportunities for mergers and acquisitions to strengthen its market position and product portfolio[40]. - The company is optimistic about future growth, projecting an increase in revenue driven by new product launches and market expansion strategies[40]. Product Development and Innovation - The company launched a dual celebrity endorsement strategy, significantly increasing brand awareness among high-end consumers and the younger generation[52]. - The company implemented AI technology across its online business operations, resulting in a 40% increase in conversion rates for late-night inquiries through its intelligent customer service system[59]. - The company has established a new division for bird's nest peptide products aims to create additional growth avenues through technological innovation[74]. - The company is focusing on developing new products that include bird's nest food and skincare products, which contain bird's nest or its extracts[40]. - The company aims to enhance its product offerings with a three-dimensional product matrix to cover various consumer scenarios[75]. Corporate Governance and Compliance - The audit committee has reviewed and confirmed the accounting principles and policies adopted by the group for the year ending December 31, 2024[121]. - The company has maintained compliance with the minimum public float percentage requirements throughout the year ending December 31, 2024[118]. - The company has not encountered any significant labor disputes and has maintained good relations with employees[115]. Future Investments and Plans - The company plans to utilize the net proceeds from the global offering, totaling approximately RMB 256.46 million, by December 31, 2028, for various strategic initiatives[112]. - The company aims to enhance its supply chain management capabilities with an investment of RMB 89.8 million by December 31, 2028[112]. - The company is focused on expanding its sales network with an investment of RMB 64.1 million by December 31, 2028[112]. - The company has committed RMB 38.5 million to strengthen brand building and marketing efforts, with no specific timeline applicable[112].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 XIAMEN YAN PALACE BIRD'S NEST INDUSTRY CO., LTD. 廈門燕之屋燕窩產業股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：1497） 須予披露交易 認購結構性存款產品 認購結構性存款產品 於2025年1月3日，本公司全資附屬公司燕之屋絲濃生物科技與中國光大銀行訂 立結構性存款產品協議I，據此，燕之屋絲濃生物科技同意向中國光大銀行認購 人民幣45百萬元的結構性存款產品I。認購的結構性存款產品I已於2025年3月3 日全部贖回。 於2025年1月6日，本公司全資附屬公司燕之屋絲濃生物科技與中國光大銀行訂 立結構性存款產品協議II，據此，燕之屋絲濃生物科技同意向中國光大銀行認購 人民幣50百萬元的結構性存款產品II。認購的結構性存款產品II已於2025年2月 17日全部贖回。 於2025年2月17日，本公司全資附屬公司燕之屋絲濃生物科技與中國光大 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 XIAMEN YAN PALACE BIRD'S NEST INDUSTRY CO., LTD. 廈門燕之屋燕窩產業股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：1497) 董事會會議召開日期 廈門燕之屋燕窩產業股份有限公司（「本公司」及其附屬公司「本集團」）董事會 （「董事會」）茲通告謹定於2025年3月14日（星期五）舉行董事會會議，以考慮及通 過本集團截至2024年12月31日止的全年業績，及建議之末期股息（如有），以及處 理其他事項。 於本公告日期，董事會包括(i)執行董事黃健先生、鄭文濱先生、李有泉先生及黃 丹艷女士；(ii)非執行董事劉震先生及王亞龍先生；及(iii)獨立非執行董事肖偉先 生、陳愛華先生及林曉波先生。 黃健 香港，2025年3月4日 承董事會命 廈門燕之屋燕窩產業股份有限公司 董事長兼執行董事 ...

我公司的这个经营上面还是比较稳定啊在24年可能整体大环境都不太好的情况下那整体公司呃收入段还是有一个呃增长然后呃尤其是公司这个20年下半年啊还是有一些明显的这个表现的啊那呃公司作为这个燕窝啊这个滋补这个品类方向的一个绝对的龙头呃 还是非常受大家关注的今天非常感谢熊总时间熊总要不先请您跟大家更新一下可能公司近期经营情况因为我看2月14号咱们也发了预告然后看有没有更多的一些关于20年的一些经营的趋势方向的一些情况跟大家做一个分享同时大家可能也比较关注春节包括春节的一个情况包括25年咱们公司的一个战略的一些方向的一些变化 然后感谢您好的好的谢谢王老师还有保罗组织这场会议然后尊敬的各位投资人我是燕租屋的董秘琼婷我给大家分享一下公司近期的一些经营方面的一个情况正向大家看到的其实我们在上周五的话我们也发布了公司的一个领域的一个预告然后我们的收入在20年 保持了一个微增的这样的一个趋势大概增幅在2%到7%然后我们的金利润考虑到上半年我们是下滑的幅度比较大我们20年上半年利润下滑了百分之四十四那我们在下半年的话也及时地根据整体环境的一个情况做了一些调整和金融上策略的一些调整然后在下半年我们也是收回了一些的增长 所以我们全联的 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不會因本公告全部或任何部分內容而產生或因依 賴該等內容而引致的任何損失承擔任何責任。 盈利警告 本公告由廈門燕之屋燕窩產業股份有限公司（「本公司」及其子公司（統稱「本集 團」））根據香港聯合交易所有限公司證券上市規則（「上市規則」）第13.09(2)(a)條 及香港法例第571章證券及期貨條例第XIVA部項下的內幕消息條文作出。 本公司董事（「董事」）會（「董事會」）謹此知會本公司股東（「股東」）及潛在投資 者，根據對本集團截至2024年12月31日止年度的未經審核綜合管理賬目的初步審 閱，並經考慮董事會現時可得資料，(i)本集團預期截至2024年12月31日止年度將 錄得收入約人民幣2,000百萬元至2,100百萬元，較截至2023年12月31日止年度增 長約2%至7%，及(ii)本集團預期截至2024年12月31日止年度的淨利潤約為人民幣 158.7百萬元至人民幣179.8百萬元，較截至2023年12月31日止年度下降約15%至 25%。 董事會認為淨利潤的預期減少主要歸因於以下原因 ...